* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Sopharma AD-Sofia's PEG Ratio or its related term are showing as below:
XBUL:SFA'
s PEG Ratio Range Over the Past 10 Years
Min: 0.29 Med: 1.03 Max: 15.11
Current: 0.65
During the past 13 years, Sopharma AD-Sofia's highest PEG Ratio was 15.11. The lowest was 0.29. And the median was 1.03.
XBUL:SFA's PEG Ratio is ranked better than 68.89% of 45
companies
in the Medical Distribution industry
Industry Median: 1.08
vs XBUL:SFA: 0.65
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Sopharma AD-Sofia PEG Ratio Historical Data
The historical data trend for Sopharma AD-Sofia's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Sopharma AD-Sofia's PEG Ratio
For the Medical Distribution subindustry, Sopharma AD-Sofia's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sopharma AD-Sofia's PEG Ratio Distribution in the Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Sopharma AD-Sofia's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Sopharma AD-Sofia's PEG Ratio falls into.
Sopharma AD-Sofia PEG Ratio Calculation
PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio.
The ratio we use is the 5-Year EBITDA growth rate.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Sopharma AD-Sofia (XBUL:SFA) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Sopharma AD-Sofia PEG Ratio Related Terms
Thank you for viewing the detailed overview of Sopharma AD-Sofia's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Sopharma AD-Sofia is a company engaged in the production of pharmaceutical products. Its principal activities include the production and trade of medicinal substances and finished drug forms; and research and development as well as engineering and implementation activities in the field of medicinal products. It is also focused on the distribution of pharmaceuticals like medical supplies, sanitary materials, vitamins, food supplements, and cosmetics. The company's segments are organized based on the production of finished products which include Tablet dosage forms, Ampoule dosage forms, Medical products, Other forms, and Other revenue. Geographically company operates in Bulgaria and internationally.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XBUL:SFA has been successfully added to your 